• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“脑保护剂”药物21-氨基类固醇对溶栓治疗实验性栓塞性中风效果的影响。

Influence of a 'brain protector' drug 21-amino steroid on the effects of experimental embolic stroke treated by thrombolysis.

作者信息

Orozco J, Mendel R C, Hahn M R, Guthkelch A N, Carter L P

机构信息

University of Arizona, Health Sciences Center, Tucson, USA.

出版信息

Neurol Res. 1995 Dec;17(6):423-5.

PMID:8622795
Abstract

This study was designed to evaluate the effects of tissue-type plasminogen activator (tPA) and 21- amino steroid (U74006F) in experimental embolic stroke in rabbits. The size of infarction from embolism was compared to controls with tPA alone, 21-amino steroid alone, and in combination. The middle cerebral artery of the rabbit was embolized by injecting an arterial ('white') thrombus in the right internal carotid artery. The rabbit treatment was 2 mg kg-1 of tissue-type plasminogen activator and/or 3 mg kg-1 of 21 amino steroid started at 2 h post-embolization. The animals were terminated 4 h post-treatment and brains were examined for evidence of ischemia and/or hemorrhage. Administration of tissue-type plasminogen activator and/or 21-amino steroid in the raw data show that there is a tendency for all treatments to reduce the ischemic volume when compared to the control group, also it is evident the standard deviation of these estimates is rather large when compared to the differences between treatments. The results of the analysis of variance shows that the differences expressed are not statistically significant. (No statistical differences were found between the treatment groups and the control group.) The results show that administration of tissue-type plasminogen activator and/or 21 amino steroid at 2 h post-embolization alone or in simultaneous administration does not significantly reduce the volume of infarction. Further studies need to be addressed in regards to the region of viable brain in the peri-infarct area, in reducing the time to treatment.

摘要

本研究旨在评估组织型纤溶酶原激活剂(tPA)和21-氨基类固醇(U74006F)对兔实验性栓塞性中风的影响。将栓塞所致梗死灶大小与单独使用tPA、单独使用21-氨基类固醇以及联合使用的对照组进行比较。通过向兔右侧颈内动脉注射动脉(“白色”)血栓来栓塞大脑中动脉。兔的治疗方案为在栓塞后2小时开始给予2mg/kg的组织型纤溶酶原激活剂和/或3mg/kg的21-氨基类固醇。在治疗后4小时处死动物,并检查大脑有无缺血和/或出血迹象。原始数据中组织型纤溶酶原激活剂和/或21-氨基类固醇的给药情况表明,与对照组相比,所有治疗组均有减少缺血体积的趋势,而且与各治疗组之间的差异相比,这些估计值的标准差相当大。方差分析结果表明,所表达的差异无统计学意义。(治疗组与对照组之间未发现统计学差异。)结果表明,在栓塞后2小时单独或同时给予组织型纤溶酶原激活剂和/或21-氨基类固醇并不能显著减少梗死体积。关于梗死周边存活脑组织区域以及缩短治疗时间,还需要进一步研究。

相似文献

1
Influence of a 'brain protector' drug 21-amino steroid on the effects of experimental embolic stroke treated by thrombolysis.“脑保护剂”药物21-氨基类固醇对溶栓治疗实验性栓塞性中风效果的影响。
Neurol Res. 1995 Dec;17(6):423-5.
2
Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits: synergism with low-dose tissue plasminogen activator.依布硒啉,一种有机硒抗氧化剂,对兔栓塞性中风具有神经保护作用:与低剂量组织纤溶酶原激活剂协同作用。
Stroke. 2003 Aug;34(8):2013-8. doi: 10.1161/01.STR.0000081223.74129.04. Epub 2003 Jul 10.
3
A comparison of intra-arterial and intravenous tissue-type plasminogen activator on autologous arterial emboli in the cerebral circulation of rabbits.动脉内与静脉内注射组织型纤溶酶原激活剂对兔脑循环中自体动脉栓子作用的比较。
Stroke. 1994 Mar;25(3):651-5; discussion 656. doi: 10.1161/01.str.25.3.651.
4
Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.自旋捕捉剂二钠-[(叔丁基亚氨基)甲基]苯-1,3-二磺酸盐N-氧化物(通用名NXY-059)在兔小血栓栓塞性中风模型中的神经保护作用:与溶栓组织纤溶酶原激活剂的联合研究
Stroke. 2002 May;33(5):1411-5. doi: 10.1161/01.str.0000015346.00054.8b.
5
Influence of tissue plasminogen activator and heparin on cerebral ischemia in a rabbit model.组织型纤溶酶原激活剂和肝素对兔脑缺血模型的影响。
Stroke. 1992 Jun;23(6):883-8. doi: 10.1161/01.str.23.6.883.
6
Usefulness of postischemic thrombolysis with or without neuroprotection in a focal embolic model of cerebral ischemia.在局灶性脑缺血栓塞模型中,缺血后溶栓联合或不联合神经保护的效用。
J Neurosurg. 2000 May;92(5):841-7. doi: 10.3171/jns.2000.92.5.0841.
7
Efficacy and safety profile of the carotenoid trans sodium crocetinate administered to rabbits following multiple infarct ischemic strokes: a combination therapy study with tissue plasminogen activator.胡萝卜素转钠 crocetinate 对多发性脑梗死缺血性中风兔的疗效和安全性:与组织型纤溶酶原激活物联合治疗的研究。
Brain Res. 2010 Jan 14;1309:136-45. doi: 10.1016/j.brainres.2009.10.067. Epub 2009 Nov 3.
8
Coadministration of NXY-059 and tenecteplase six hours following embolic strokes in rabbits improves clinical rating scores.在兔栓塞性中风6小时后联合给予NXY - 059和替奈普酶可改善临床评分。
Exp Neurol. 2004 Aug;188(2):279-85. doi: 10.1016/j.expneurol.2004.02.005.
9
Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke.溶栓与胞磷胆碱联合治疗对大鼠栓塞性脑卒中模型的影响。
J Neurol Sci. 2006 Sep 25;247(2):121-9. doi: 10.1016/j.jns.2006.03.022. Epub 2006 Jun 22.
10
Delayed adjuvant therapy with the 21-aminosteroid U74006F and the anion channel blocker L644-711 does not improve outcome following thrombolytic therapy in a rabbit model of thromboembolic stroke.在兔血栓栓塞性中风模型中,使用21-氨基类固醇U74006F和阴离子通道阻滞剂L644-711进行延迟辅助治疗并不能改善溶栓治疗后的预后。
Surg Neurol. 1997 Jan;47(1):60-5; discussion 66-7. doi: 10.1016/s0090-3019(96)00249-2.

引用本文的文献

1
Publication bias in reports of animal stroke studies leads to major overstatement of efficacy.动物中风研究报告中的发表偏倚导致疗效的严重夸大。
PLoS Biol. 2010 Mar 30;8(3):e1000344. doi: 10.1371/journal.pbio.1000344.
2
Can the time window for administration of thrombolytics in stroke be increased?中风溶栓治疗的时间窗可以延长吗?
CNS Drugs. 2003;17(14):995-1011. doi: 10.2165/00023210-200317140-00001.